Resource • Article
Biorasi Recognized by Frost and Sullivan with the 2020 North American Entrepreneurial Company of the Year Award
Biorasi Recognized on Inc. 5000 List of Fastest-Growing Private Companies of the Year Award
MIAMI, FL (October 5, 2020) – Biorasi, a leading global full-service contract research organization (CRO), has been recognized by Frost & Sullivan as the North American CRO Entrepreneurial Company of the Year. This is the first time that Biorasi has received this prestigious Best Practices Award, which recognizes individual companies for superior leadership and innovation across multiple industries.
“This recognition is a testament to all that we are doing here as a company, and the vision we see for the future of clinical research – to bring therapies to all kinds of patients, especially underserved patient populations such as those suffering from rare and orphan diseases,” said Wayne Bowden, VP of Program Development at Biorasi. “In the report, Frost and Sullivan point to our innovative approaches to patient recruitment in these difficult spaces as a way we can ensure better results, faster, for our partners and their patients.”
A Leader in the CRO Industry
Established in 2002, Biorasi emerged as a clinical trial rescue partn viable er , offering smart solutions for studies facing delays and other timeline challenges. Today, pharmaceutical and medical device companies rely on Biorasi to deliver success in clinical trial programs for rare and orphan diseases, neurology, nephrology, dermatology, oncology, and the emerging digital therapeutics market. The company has also expanded its solutions to leverage decentralized trial srategies in the wake of the coronavirus pandemic, as well as executing COVID-19 studies for vaccines and treatments for the after-effects of the disease.
“This award is a compliment, not just to the company, but to each of our employees,” said Chris O’Brien, CEO at Biorasi. “It is the entrepreneurial spirit in Biorasi that enables us to meet difficult deadlines, to develop better and more efficient ways of working, and to enable critical research for our sponsors.”
For more information:
- Click here to read the full press release from Frost and Sullivan.
- Explore the Frost and Sullivan Best Practices Overview of Biorasi.
Biorasi is a customer-focused, full-service, contract research organization (CRO) that leverages speed and agility in the execution of clinical trials to maximize speed-to-market for its sponsors – all powered by our proprietary TALOS™ project management system. Biorasi is a leader in neurology, nephrology, dermatology, oncology, and the emerging digital therapeutics market. To learn more, contact Biorasi at email@example.com / (786) 388-0700.